Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01678222 · ClinicalTrials.gov registry record
The COX-2 Gene and the Immune System
A clinical trial, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- Completed
- Registry status
- 117
- Enrollment target
NCT01678222 is a clinical trial that has completed, run by National Institute of Environmental Health Sciences (NIEHS). The registered enrollment target is 117 participants.
The verdict
NCT01678222 has completed, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- COMPLETED
- Registry status
- 117 participants
- Enrollment target
Study Summary
Background: \- The immune system contains several different types of cells in the blood and other parts of the body. The body can fight infections well with the right balance of these cell types. The wrong balance of cell types may cause diseases, such as allergies or asthma. The COX-2 gene may help decide the balance of cell types that the body makes as part of the immune system. It may also play a role in certain immune system diseases. Researchers want to see how COX-2 affects the cells in the immune system. Objectives: \- To study how the COX-2 gene works in the body s immune system. Eligibility: \- Individuals 18 years of age and above who are part of the Environmental Polymorphisms Registry. Design: * Participants will have one study visit at the National Institutes of Health. They will collect a urine sample at home on the morning of the study visit. * Participants will have a physical exam and medical history. They will provide a blood sample. They will also give researchers the urine sample they collected that morning. * No treatment will be provided as part of this study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2013-05-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01678222
The ClinicalTrials.gov registry entry for NCT01678222 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 117 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Environmental Health Sciences (NIEHS), which has 145 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01678222 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01678222 about?
NCT01678222 is a clinical study titled "The COX-2 Gene and the Immune System". Background: \- The immune system contains several different types of cells in the blood and other parts of the body. The body can fight infections well with the right balance of these cell types. The wrong balance of cell types may cause diseases, such as allergies or asthma. The COX-2 gene may hel...
What is the current status of trial NCT01678222?
This trial is currently completed. The enrollment target is 117 participants. The study started on 2013-05-02.
Who is sponsoring clinical trial NCT01678222?
This trial is sponsored by National Institute of Environmental Health Sciences (NIEHS), which has 145 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.